These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1737087)

  • 21. Acute leukaemia in bcr/abl transgenic mice.
    Heisterkamp N; Jenster G; ten Hoeve J; Zovich D; Pattengale PK; Groffen J
    Nature; 1990 Mar; 344(6263):251-3. PubMed ID: 2179728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of Pax5 Exploits Sca1-BCR-ABL
    Martín-Lorenzo A; Auer F; Chan LN; García-Ramírez I; González-Herrero I; Rodríguez-Hernández G; Bartenhagen C; Dugas M; Gombert M; Ginzel S; Blanco O; Orfao A; Alonso-López D; Rivas JL; García-Cenador MB; García-Criado FJ; Müschen M; Sánchez-García I; Borkhardt A; Vicente-Dueñas C; Hauer J
    Cancer Res; 2018 May; 78(10):2669-2679. PubMed ID: 29490943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway.
    Wang X; Yang J; Guo G; Feng R; Chen K; Liao Y; Zhang L; Sun L; Huang S; Chen JL
    Mol Cancer; 2019 Apr; 18(1):84. PubMed ID: 30961617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells.
    Waldron T; De Dominici M; Soliera AR; Audia A; Iacobucci I; Lonetti A; Martinelli G; Zhang Y; Martinez R; Hyslop T; Bender TP; Calabretta B
    Leukemia; 2012 Apr; 26(4):644-53. PubMed ID: 21960247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sequential analysis of p210- and p190-bcr-abl by RT-PCR after allogeneic bone marrow transplantation for p210/p190-bcr-abl double positive acute lymphoblastic leukemia].
    Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Motomura S; Kodama F; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Feb; 42(2):89-93. PubMed ID: 11280922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation.
    Radich J; Gehly G; Lee A; Avery R; Bryant E; Edmands S; Gooley T; Kessler P; Kirk J; Ladne P; Thomas ED; Appelbaum FR
    Blood; 1997 Apr; 89(7):2602-9. PubMed ID: 9116308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias.
    Honda H; Oda H; Suzuki T; Takahashi T; Witte ON; Ozawa K; Ishikawa T; Yazaki Y; Hirai H
    Blood; 1998 Mar; 91(6):2067-75. PubMed ID: 9490692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of rac3 null mutant mice: role of Rac3 in Bcr/Abl-caused lymphoblastic leukemia.
    Cho YJ; Zhang B; Kaartinen V; Haataja L; de Curtis I; Groffen J; Heisterkamp N
    Mol Cell Biol; 2005 Jul; 25(13):5777-85. PubMed ID: 15964830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invadopodia and rolling-type motility are specific features of highly invasive p190(bcr-abl) leukemic cells.
    Daubon T; Rochelle T; Bourmeyster N; Génot E
    Eur J Cell Biol; 2012; 91(11-12):978-87. PubMed ID: 22717125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Philadelphia chromosome as a secondary abnormality in inv(3)(q21q26) acute myeloid leukemia at diagnosis: confirmation of p190 BCR-ABL mRNA by real-time quantitative polymerase chain reaction.
    Han JY; Theil KS
    Cancer Genet Cytogenet; 2006 Feb; 165(1):70-4. PubMed ID: 16490599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p190 BCR-ABL rearrangement in chronic myeloid leukemia and acute lymphoblastic leukemia.
    Lemes A; Gómez Casares MT; de la Iglesia S; Matutes E; Molero MT
    Cancer Genet Cytogenet; 1999 Aug; 113(1):100-2. PubMed ID: 10459357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment, characterization, and chromosomal analysis of new leukemic cell lines derived from MT/p210bcr/abl transgenic mice.
    Honda H; Ohno S; Takahashi T; Takatoku M; Yazaki Y; Hirai H
    Exp Hematol; 1998 Mar; 26(3):188-97. PubMed ID: 9502614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimeric BCR-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Gehly GB; Bryant EM; Lee AM; Kidd PG; Thomas ED
    Blood; 1991 Jul; 78(2):458-65. PubMed ID: 2070081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.
    Pear WS; Miller JP; Xu L; Pui JC; Soffer B; Quackenbush RC; Pendergast AM; Bronson R; Aster JC; Scott ML; Baltimore D
    Blood; 1998 Nov; 92(10):3780-92. PubMed ID: 9808572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis.
    Koschmieder S; Göttgens B; Zhang P; Iwasaki-Arai J; Akashi K; Kutok JL; Dayaram T; Geary K; Green AR; Tenen DG; Huettner CS
    Blood; 2005 Jan; 105(1):324-34. PubMed ID: 15331442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course.
    Kurzrock R; Kantarjian HM; Shtalrid M; Gutterman JU; Talpaz M
    Blood; 1990 Jan; 75(2):445-52. PubMed ID: 2403827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines.
    Suh SP; Kee SJ; Lim WH; Song JW; Lee SK; Kim JP; Shin JH; Ryang DW
    Clin Chem Lab Med; 2000 Sep; 38(9):939-44. PubMed ID: 11097354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.